S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
5 Hypergrowth Stocks to Buy Now (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
5 Hypergrowth Stocks to Buy Now (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
5 Hypergrowth Stocks to Buy Now (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
5 Hypergrowth Stocks to Buy Now (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
TSE:EXE

Extendicare - EXE Stock Forecast, Price & News

C$6.40
+0.09 (+1.43%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
C$6.31
▼
C$6.42
50-Day Range
C$6.08
▼
C$6.77
52-Week Range
C$6.02
▼
C$8.00
Volume
115,417 shs
Average Volume
158,280 shs
Market Capitalization
C$542.27 million
P/E Ratio
N/A
Dividend Yield
7.50%
Price Target
C$7.25

Extendicare MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
13.3% Upside
C$7.25 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.20 out of 5 stars

See Top Rated MarketRank™ Stocks Here

EXE stock logo

About Extendicare (TSE:EXE) Stock

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.

Receive EXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

EXE Stock News Headlines

March 25, 2023 | americanbankingnews.com
Extendicare (TSE:EXE) Hits New 52-Week Low at $6.06
March 15, 2023 | finance.yahoo.com
Extendicare Announces March 2023 Dividend of C$0.04 per Share
April 1, 2023 | Investorplace Media (Ad)
This Tech Stock Could be the Next Amazon
You can learn its name in Luke Lango’s latest report, 5 Hypergrowth Stocks for 2023. Claim Your Free Report Here. pixel
March 2, 2023 | finance.yahoo.com
Extendicare Announces 2022 Fourth Quarter and Year End Results
February 15, 2023 | finance.yahoo.com
Extendicare Announces February 2023 Dividend of C$0.04 per Share
January 20, 2023 | finance.yahoo.com
Extendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04
January 19, 2023 | finance.yahoo.com
Extendicare Announces Timing of Fourth Quarter and Fiscal 2022 Results and Conference Call
January 16, 2023 | finance.yahoo.com
Extendicare Announces January 2023 Dividend of C$0.04 per Share
April 1, 2023 | Legacy Research (Affiliate) (Ad)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.
December 15, 2022 | finance.yahoo.com
Extendicare Announces December 2022 Dividend of C$0.04 per Share
November 13, 2022 | finance.yahoo.com
Extendicare Third Quarter 2022 Earnings: CA$0.041 loss per share (vs CA$0.027 profit in 3Q 2021)
November 12, 2022 | finance.yahoo.com
Those who invested in Extendicare (TSE:EXE) five years ago are up 10%
October 19, 2022 | globenewswire.com
Global Home Healthcare Services Market to Acquire an Impressive Revenue by 2033 and to Grow with a CAGR of - GlobeNewswire
October 18, 2022 | benzinga.com
Extendicare Announces October 2022 Dividend of C$0.04 per Share - Benzinga
October 17, 2022 | finance.yahoo.com
Extendicare Announces October 2022 Dividend of C$0.04 per Share
October 16, 2022 | ca.finance.yahoo.com
TFSA Passive Income: Make $526/Month Tax Free With Healthcare Stocks - Yahoo Canada Finance
October 15, 2022 | fool.ca
TFSA Passive Income: Make $526/Month Tax Free With Healthcare Stocks - The Motley Fool Canada
October 14, 2022 | ca.finance.yahoo.com
2 Top Healthcare Stocks Defying the Bear Market - Yahoo Canada Finance
October 13, 2022 | finance.yahoo.com
Does This Valuation Of Extendicare Inc. (TSE:EXE) Imply Investors Are Overpaying?
October 13, 2022 | theglobeandmail.com
Extendicare's exit in Saskatchewan heralds end of private for-profit long-term care - The Globe and Mail
October 12, 2022 | fool.ca
2 Top Healthcare Stocks Defying the Bear Market - The Motley Fool Canada
October 7, 2022 | ca.finance.yahoo.com
Trevali Announces Application for Judicial Liquidation of 90%-Owned Burkina Faso Subsidiary; Extension of CCAA Stay of Proceedings - Yahoo Canada Finance
October 6, 2022 | finance.yahoo.com
Extendicare Announces Timing of 2022 Third Quarter Results and Conference Call - Yahoo Finance
October 6, 2022 | finance.yahoo.com
Extendicare Announces Timing of 2022 Third Quarter Results and Conference Call
October 1, 2022 | fool.ca
My 3 Favourite TSX Stocks for Passive Income - The Motley Fool Canada
September 25, 2022 | fool.ca
TFSA Passive Income: Make $455/Month Tax Free for Life - The Motley Fool Canada
September 19, 2022 | theglobeandmail.com
Extendicare: Top 10 Undervalued Healthcare Providers & Services Industry Stocks on TSE (EXE)
See More Headlines
Receive EXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

EXE Company Calendar

Ex-Dividend for 3/15 Dividend
2/27/2023
Dividend Payable
3/15/2023
Ex-Dividend for 4/17 Dividend
3/30/2023
Today
4/01/2023
Dividend Payable
4/17/2023
Next Earnings (Estimated)
5/11/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Long - Term Care Facilities
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:EXE
CUSIP
N/A
CIK
N/A
Web
www.extendicare.com
Phone
905-470-4000
Fax
N/A
Employees
23,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$7.25
High Stock Price Forecast
C$8.00
Low Stock Price Forecast
C$7.00
Forecasted Upside/Downside
+13.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
C($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
35.11
P/E Growth
N/A
Net Income
C$-4,510,000.00
Net Margins
5.69%
Pretax Margin
N/A
Return on Equity
-4.45%
Return on Assets
1.92%

Debt

Debt-to-Equity Ratio
381.30
Current Ratio
0.94
Quick Ratio
0.98

Sales & Book Value

Annual Sales
C$1.22 billion
Price / Sales
0.44
Cash Flow
C$2.00 per share
Price / Cash Flow
3.20
Book Value
C$1.19 per share
Price / Book
5.38

Miscellaneous

Outstanding Shares
84,730,000
Free Float
N/A
Market Cap
C$542.27 million
Optionable
Not Optionable
Beta
1.19

Key Executives

  • Dr. Michael R. Guerriere M.D. (Age 59)
    MBA, CEO, Pres & Director
    Comp: $1.13M
  • Mr. David E. Bacon
    Sr. VP & CFO
  • Mr. John Toffoletto
    Sr. VP, Chief Legal Officer & Corp. Sec.
  • Ms. Leslie Sarauer (Age 61)
    Sr. VP & Chief HR Officer
    Comp: $567.15k
  • Mr. Ali Mohammad Mir
    VP, ParaMed Operations
  • Mr. Steve Paraskevopoulos
    Sr. VP of ParaMed & CTO
  • Ms. Jillian E. Fountain
    VP of Investor Relations
  • Ms. Lisa Pearson
    VP of Public Affairs
  • Ms. Elaine E. Everson
    VP of Corp. Devel.
  • Dr. Matthew Morgan
    Chief Medical Officer

Key Competitors

View All Competitors













EXE Stock - Frequently Asked Questions

Should I buy or sell Extendicare stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" EXE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares.
View EXE analyst ratings or view top-rated stocks.

What is Extendicare's stock price forecast for 2023?

3 brokers have issued 12 month price targets for Extendicare's stock. Their EXE share price forecasts range from C$7.00 to C$8.00. On average, they anticipate the company's share price to reach C$7.25 in the next year. This suggests a possible upside of 13.3% from the stock's current price.
View analysts price targets for EXE or view top-rated stocks among Wall Street analysts.

How have EXE shares performed in 2023?

Extendicare's stock was trading at C$6.56 on January 1st, 2023. Since then, EXE stock has decreased by 2.4% and is now trading at C$6.40.
View the best growth stocks for 2023 here.

When is Extendicare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our EXE earnings forecast.

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?

Extendicare announced a monthly dividend on Wednesday, March 15th. Stockholders of record on Friday, March 31st will be paid a dividend of 0.04 per share on Monday, April 17th. This represents a $0.48 dividend on an annualized basis and a yield of 7.50%. The ex-dividend date is Thursday, March 30th.
Read our dividend analysis for EXE.

Is Extendicare a good dividend stock?

Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 7.86%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for EXE.

What other stocks do shareholders of Extendicare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA).

What is Extendicare's stock symbol?

Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE."

How do I buy shares of Extendicare?

Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Extendicare's stock price today?

One share of EXE stock can currently be purchased for approximately C$6.40.

How much money does Extendicare make?

Extendicare (TSE:EXE) has a market capitalization of C$542.27 million and generates C$1.22 billion in revenue each year. The company earns C$-4,510,000.00 in net income (profit) each year or C($0.05) on an earnings per share basis.

How many employees does Extendicare have?

The company employs 23,000 workers across the globe.

How can I contact Extendicare?

The official website for the company is www.extendicare.com. The company can be reached via phone at 905-470-4000.

This page (TSE:EXE) was last updated on 4/1/2023 by MarketBeat.com Staff